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ABSTRACT
Acute Hepatopancreatic Necrosis Disease (AHPND) causes more than a billion
dollars of losses to the shrimp farming industry annually. In 2013, strains of the
marine pathogen Vibrio parahaemolyticus containing genes for the PirAVp/BVp toxins,
encoded on a 70 Kb plasmid, were identified as the causative agent of AHPND.
Antibiotics have been used to attempt to reduce losses, however their use in
aquaculture is controversial. Additionally, the pathogen has demonstrated the ability
to rapidly acquire antibiotic resistances through genetic mutation and lateral gene
transfer. Probiotics, often used to prevent disease in aquaculture, may offer the
opportunity to mitigate AHPND infections without the risks to consumers and the
environment posed by antibiotic use. The goal of this study was to determine if the
marine probiont Phaeobacter inhibens S4 protects Litopenaeus vannamei post-larvae
(PLs) against fatal V. parahaemolyticus infections and to elucidate its protective
mechanisms. A further goal of this study was to isolate and identify other potential
probionts, including “Bdellovibrio and Like Organisms” (BALO), whose prey range
includes V. parahaemolyticus.
P. inhibens S4 was tested in challenge assays using Artemia nauplii and L.
vannamei for its ability to protect these organisms from V. parahaemolyticus-induced
mortality. Zhao et al previously identified three key probiotic activities of P. inhibens
S4: 1) the production of the antibiotic compound tropodithietic acid (TDA), 2) the
formation of a copious biofilm, and 3) quorum sensing/quorum quenching activity
through N-acyl homoserine lactone (AHL) signaling. Mutant strains of P. inhibens S4

with one or a combination of these three mechanisms altered were used in PL
challenge assays to asses which probiotic functions were key to protecting shrimp.
Competition assays, to assess in vitro growth of V. parahaemolyticus PSU5579 when
co-cultured with P. inhibens S4 or one of the mutant strains, were also performed to
determine the ability of S4 to inhibit the growth of the pathogen in biofilms and
planktonic states. Results showed that P. inhibens S4SmKm protects L. vannamei PLs
from AHPND, increasing survival from 45% in the infected control to 80% when the
environment is pre-treated with P. inhibens S4SmKm. Assays with wild type and
mutant strains of P. inhibens show protection whether or not TDA is produced;
however, S4 no longer protects when biofilm production is reduced or quorum
sensing/quorum quenching is disrupted. In support of these results, it was shown
that P. inhibens S4 does not inhibit the growth of V. parahaemolyticus when cocultured, nor is V. parahaemolyticus sensitive to the antibiotic TDA, even up to
concentrations of 100 µg/ml.
To screen for other potential probionts and a BALO organism, bacteria
isolated from seawater and shrimp tank water were screened using a zones of
inhibition (ZOI) assay and for plaque forming capabilities in lawns of V.
parahaemolyticus.

A candidate BALO was isolated from Narragansett Bay that

showed predatory activity against V. parahaemolyticus. Genomic DNA was extracted,
and the genome was sequenced. The organism appears to be a previously
unidentified species of Halobacteriovorax, given the strain name GB3. While
Halobacteriovorax GB3 does not harm L. vannamei PLs, we did not test its ability to

protect shrimp from AHPND because it does not reduce V. parahaemolyticus
concentrations below 1×106 CFU/ml, which is an infectious dose.
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PREFACE
The following thesis has been prepared in manuscript format according to the
guidelines of the Graduate School of the University of Rhode Island. This thesis
contains a literature review and two manuscripts.
The first manuscript “Investigating the probiotic activities of Phaeobacter
Inhibens S4 against AHPND-inducing Vibrio parahaemolyticus” will be submitted to
Applied and Environmental Microbiology.
The second manuscript “Draft Genome Sequence of Halobacteriovorax sp.
Strain GB3, a Predatory Bacterium Isolated from Narragansett Bay that Preys on
Shrimp Pathogen Vibrio parahaemolyticus PSU5579” will be submitted to
Microbiology Resource Announcements.
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REVIEW OF LITERATURE

Statement of the problem
Shrimp aquaculture is a multi-billion dollar global industry with production
estimated between 2.9-3.5 billion tons in 2017 with 75-80% of production originating
in South East Asia (1). In the United States alone, shrimp imports in 2017 were worth
$6.5 billion, an increase of 14% from the year before (1). Acute Hepatopancreatic
Necrosis Disease (AHPND) is the major cause of Early Mortality Syndrome (EMS),
responsible for significant losses in the shrimp farming industry. EMS emerged in
2009 affecting shrimp farms in southern China, causing up to 100% mortality in
shrimp ponds within 30 days (2). The disease in shrimp is characterized by a pale and
atrophied hepatopancreas and an empty gut (3). By 2014, AHPND had spread to
Vietnam, Malaysia, Thailand, Mexico and the Philippines (2). The primary cause of
AHPND has been has been identified as strains of Vibrio parahaemolyticus that
produce PirA and PirB toxins (encoded by pirA and pirB, respectively) and contain an
antibacterial Type VI secretion system (T6SS) (3). Utilizing antibiotics to control
AHPND has not been a successful strategy (4). Multi-antibiotic resistant strains of V.
parahaemolyticus have been isolated from shrimp farms world-wide (5).
Additionally, there is public health concern about the rise of antibiotic resistant
organisms. Many bacteria, including V. parahaemolyticus, acquire and transfer new
antibiotic resistances through lateral gene transfer (6), demonstrating the dangers of
wide-scale application of antibiotics in aquaculture. Furthermore, as invertebrates,
1

shrimp lack an acquired immune system, posing challenges to vaccine
development. Probiotics, defined as “live microorganisms, conferring a healthy
benefit on the host when being consumed in adequate amounts” (7) are becoming a
preferred method to prevent bacterial infections in aquaculture (8). Recent data
indicate that Phaeobacter inhibens S4Sm, which has shown significant inhibitory
activity against other Vibrio species such as of Vibrio anguillarum and Vibrio
coralliilyticus RE22 (9) (10) 11), also has potential as a probiotic treatment in shrimp
aquaculture to prevent AHPND (12). In addition to P. inhibens, we have isolated and
investigated two other bacterial strains: Pseudoalteromonas piscicida JC3, which has
recently been shown to inhibit the growth of multiple Vibrio species including V.
parahaemolyticus (13), and a previously unidentified member of the BALO genus,
Halobacteriovorax strain GB3.
Background on shrimp farming
Aquaculture is the world’s fastest growing food production sector with an
average annual growth rate of 8% (14). Shrimp, second only to salmon and trout,
accounted for 17% of the global trade in aquaculture species by value in 2017
(approximately $6 billion) (15). While shrimp farming has been a traditional means
of growing food for thousands of years, the rise of large-scale farming for export
began in the 1980s, driven by high demand and prices in the United States and Japan
(14). The rapid rise in shrimp farming has had significant impacts on the coastal
landscapes, especially in South East Asia, with the destruction of salt flats, coastal
wetlands, mangroves, and agricultural land converted to brackish water ponds for
2

farming shrimp due to its value as a crop (16). Farming practices vary widely both
regionally and within a given region, but shrimp ponds are either closed systems into
which water is pumped and then pumped off when the ponds are emptied, or open
systems which exchange water at some interval, up to 20% daily (17). Effluent from
shrimp ponds degrades the water quality in the surrounding areas by adding
suspended solids, nutrients, and organic matter, contributing to eutrophication of
coastal waters (16). Outbreaks of disease in these ponds often lead to massive crop
losses. Around the turn of the 21st century, hatcheries began captive breeding
programs with Litopenaeus vannamei (whiteleg shrimp) to produce Specific Pathogen
Free (SPF), Specific Pathogen Resistant (SPR), and Specific Pathogen Tolerant (SPT)
brood stock. As a result, white leg shrimp are now the most commonly farmed
species of shrimp (14). Ponds are stocked with Post Larval Shrimp (PLs), which are
then harvested when mature.

Rise and spread of AHPND
Originally named Early Mortality Syndrome, AHPND was first reported in
China in 2009. By 2011 it had spread to Malaysia and Vietnam and in 2012 to
Thailand. The causative agent was isolated in 2013 (18), also in 2013 AHPND was
confirmed in Mexico (19). Clinical appearance includes a pale to white
hepatopancreas (HP), reduced HP size, empty stomach (ST), and empty midgut (MG)
(Fig. 1). The impact of the disease was a rapid decline in the rate of production, such
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as was seen in Thailand where production peaked in 2012 and decreased sharply
with the emergence of AHPND (Fig 2).

Figure 1. Characteristics of AHPND. A and B show signs of disease post challenge
with V. parahaemolyticus including atrophied, pale HP, empty ST and empty MG. C
and D are examples of healthy shrimp. (18)

Figure 2: Farmed shrimp production in Thailand from 1970-2015. The steep decline
in production between 2010 and 2015 coincides with the emergence of AHPND in
2012. (1)
4

Vibrio parahaemolyticus as pathogen
V. parahaemolyticus is also known as a human pathogen; however, there are
key differences between the strains that cause gastroenteritis in humans and those
causing AHPND in shrimp. V. parahaemolyticus has two type six secretion systems
(T6SS1 and T6SS2) located on chromosome one and two, respectively. T6SS1 is most
active in high salinity conditions and appears to target bacteria, whereas T6SS2 is
active in low salinity, such as inside the guts of host organisms (20). The antibacterial
T6SS1, when activated by the high salinity of shrimp ponds, gives V.
parahaemolyticus a competitive advantage as it is able to attack and kill other
bacteria competing to fill niches in these aquatic environments. Additionally, strains
pathogenic to shrimp contain a Type Three Secretion System 1 (T3SS1), but lack a
T3SS2, which is present in all human clinical strains and considered an important
factor for human virulence (21). Further, V. parahaemolyticus strains pathogenic to
humans contain the thermostable direct hemolysin (tdh) and tdh-related hemolysin
(tdr) genes; however, neither of these genes are found in AHPND-inducing strains
(21, 22).
PirA/B-containing plasmid
The PirAVp/BVp toxins are encoded on a highly conserved 70 Kb plasmid and
flanked by transposases. It has been described as a “selfish plasmid” (3) because the
plasmid also encodes for conjugative transfer gene clusters and a post-segregational
killing system (PSK) associated gene pndA (23,24) (Fig. 3). Selfish genetic elements
5

are those that enhance their own transmission without necessarily conferring a
benefit to the individual (25); the conjugative transfer gene cluster increases the
likelihood of transfer (24). The PSK ensures that any bacterial progeny without the
plasmid will die; this system encodes for a highly stable antibacterial mRNA which
persists following cell division, along with a less stable and complementary antisense
RNA which quickly degrades so that cells without the plasmid-based PSK are killed by
the antibacterial mRNA (26). It is well documented that lateral gene transfer occurs
among Vibrio species of the same clade, so it is not surprising to note that this
plasmid has also been isolated from other members of the V. harveyi clade including
Vibrio campbelli and Vibrio owensii (23, 27, 28) (Fig. 4). However, it is notable that
the plasmid has also been isolated from more distantly related species and the
pirAVp/BVp genes have also been observed in Micrococcus luteus strains isolated in
Mexico (29).

Figure 3. Genetic map of the 70 Kb AHPND associated plasmid. The genetic
elements of the plasmid include pirAvp/pirBvp flanked by transposases as well as a
Type II Secretion System. The presence of a conjugative transfer gene cluster and the
6

PSK associated pndA gene enhance the transfer of the plasmid and ensure its
presence in subsequent progeny (24).
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Figure 4. Sequence map and identity plot of AHPND associated plasmid extracted
from V. owensii. Mapping shows greater than 99% identity with AHPND associated
plasmids extracted from V. parahaemolyticus (blue) and V. harveyi (green) when
compared to the reference sequence from V. owensii (grey) demonstrating that the
plasmid is highly conserved across species. Used with permission.(23)

Issues with antibiotics
The use of antibiotics in aquaculture is widespread and problematic for many
reasons. Residual antibiotics linger in the environment, altering microflora and
selecting for antibiotic-resistant bacteria (30). There is a potential for human harm as
well since residual antibiotics have been observed on aquaculture products from
China, including shrimp. Though not well studied as a side effect of antibiotic use in
aquaculture, one potential risk to humans includes allergic reactions (31). The
greatest threat, however, to human populations is likely the rise in antibiotic
resistance. The data suggest that there is a strong link between the use of antibiotics
in aquaculture and the increased frequency of drug resistant strains of pathogenic
bacteria (32). Furthermore, the use of fluoroquinolones has become increasingly
common in aquaculture. Unfortunately, this class of antibiotics which do not readily
biodegrade, also accumulate in the tissues of farmed aquatic species (32) increasing
the potential for human adverse reaction and antibiotic resistance to a class of drugs
originally developed to address the issue of drug-resistant pathogens (33).

8

Other novel therapies
One central dogma of evolutionary immunology is that shrimp, as
invertebrates, lack a true adaptive immune system (34). However, research over the
past two decades has demonstrated that shrimp can develop an immune “memory”
or response to immune priming to both viral and bacterial pathogens following
vaccination and other exposure to pathogens (34–37); however, it is important to
note that V. parahaemolyticus does not appear to colonize the shrimp gut, and
therefore vaccination or similar immune stimulus to the pathogen is not likely to
increase survival. Recent studies have shown an ability to stimulate increased
immune response to protect shrimp from AHPND through non-lethal heat shock,
which upregulates heat shock proteins (38, 39), and through passive “vaccination”
with feed-base exposure to the PirA toxin by adding anti-PirA-toxin immunoglobulin
(IgY) from chicken egg yolk to feed (40) that render the shrimp less susceptible to the
toxin itself. Another emerging area of research in control of bacterial illness is
bacteriophage therapy, which is the application of bacteriophage viruses that infect
and kill the pathogenic bacteria without harm to the host organism. There are many
challenges to utilizing this treatment method, and phage therapy would be
ineffective as a therapy for AHPND for two reasons. First, the viruses are species
specific and sometimes strain specific, so as the pirAvp/pirBvp genes continue to be
transferred to other Vibrio species, this treatment will become increasingly
ineffective. Second, bacteria evolve resistance to phages quickly, and some strains of
AHPND-inducing V. parahaemolyticus are naturally resistant to phage infection (41).
9

The application of bacteriophage may initially be an effective means to slow or stop
some infections; however, repeated use will increasingly select for phage resistant
strains of V. parahaemolyticus, requiring an ongoing search for new phage strains
and rendering this therapy inefficient for long-term application.
Probiotics in aquaculture
Investigations into the use of probiotics in aquaculture date back to the
1980’s (42). In aquaculture, probiotics may be applied and interact differently than in
other systems. They may be administered with feed or applied directly to the water.
In addition to inhibiting pathogen growth through the production antibiotic
compounds, probiotics can limit pathogen growth by competing for nutrients (Fig. 5)
(43). Probiotics can also protect host organisms by stimulating innate immune
response and enhancing disease resistance, as multiple Bacillus species have been
shown to do in shrimp aquaculture (35,44,45)

10

Figure 5. The applications and benefits of probiotics in shrimp aquaculture.
Probiotics can be applied directly to the environment or in feed-based supplements.
Benefits include enhanced immunity, the inhibition of pathogens and increased
growth (43).

Phaeobacter inhibens S4Sm
P. inhibens S4Sm, isolated from a healthy oyster (10) is a Gram negative,
motile rod-shaped marine member of the Roseobacter clade of Alphaproteobacteria
(46). P. inhibens S4Sm is a spontaneous streptomycin-resistant (SmR) of S4 (9). It has
strong biofilm formation capabilities and produces tropodithietic acid (TDA), which
has been shown to be a potent antibiotic against multiple Vibrio species (9, 47). P.
inhibens has been shown to be an effective probiotic against fish pathogen V.
anguillarum, as well as oyster-associated pathogens V. vulnificus and V. coralliilyticus
(9–11, 47, 48). Probiotic activity of P. inhibens S4Sm has been previously attributed
to TDA production, biofilm formation, and acyl homoserine production (Fig. 6) (9, 49).
Prior research by LaPorte and Nelson showed that P. inhibens S4Sm significantly
increased shrimp survival from V. parahaemolyticus induced AHPND compared to the
AHPND infection control and many other probiont candidates (Fig. 7) (12). Only
Pseudoalteromonas piscicida provided similar protection against AHPND as P.
inhibens S4Sm.
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Figure 6. Oyster larvae survival in the presence of P. inhibens strains after challenge
with V. coralliilyticus. The P. inhibens S4Sm strains (1 × 104 CFU/ml) were introduced
24 h before larvae were challenged with V. coralliilyticus RE22Sm (1 × 105 CFU/ml).
clpX mutants have normal biofilm formation but no TDA production. exoP mutants
produce TDA, but biofilm formation is reduced to 40% compared to wild type. Oyster
larvae treated only with artificial seawater served as control (mock). Oyster larvae
survival (% ±SD) was determined 24 h after challenge with RE22Sm. Bars marked with
an asterisk (*) show significant differences (t-test, p <0.05). Representative of at least
3 experiments. Error bars represent one standard deviation (9).
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Figure 7. Effect of preincubation of L. vannamei PLs with candidate probionts on
survival 48 h after challenge with V. parahaemolyticus PSU5579Sm. PL’s were
preincubated with P. inhibens S4Sm, Ps. piscicida JL1Sm, Ps. piscicida JL15Sm, Ps.
arabiensis JL29Sm, B. denitrificans JL63Sm, and B. pumilus RI06-95Sm for 24 h prior
to challenge with PSU5579Sm. Candidate probionts were added at 106 CFU/ml at the
start of the experiment and every 24 h thereafter. Challenge with V.
parahaemolyticus PSU5579Sm (at 106 CFU/ml) occurred 24 h after the addition of the
probionts. Representative of three independent experiments with three technical
replicates per experiment. Error bars equal one standard deviation. * Indicates
statistically significant difference from the V. parahaemolyticus PSU5579Sm
treatment (ANOVA, p <0.05) (12).

Halobacteriovorax
Halobacteriovorax is a genus of predatory marine bacteria within the
Deltaproteobacteria; it was first differentiated from freshwater genus Bacteriovorax
in 2015 (50). Currently, two named species belong to this genus: Halobacteriovorax
litoralis and Halobacteriovorax marinus (50, 51). This genus shares many
13

characteristics with the predatory genus Bdellovibrio including its unique, two-phase
life cycle in which it attacks a Gram-negative bacterium in its prey range, penetrates
the cell into the periplasm and replicates inside the periplasm using the nutrients
provided by the prey cell (52). Organisms with this unique life cycle are often
grouped together into a class called Bdellovibrio and Like Organisms (BALOs). It has
been proposed that BALOs could help prevent AHPND in shrimp aquaculture (53).
Halobacteriovorax sp. GB3 was isolated from Narragansett Bay and tested against a
strain of AHPND-inducing Vibrio parahaemolyticus.

Research Goals

The overall goal of this research was to examine the interactions between V.
parahaemolyticus and potential probiotic organisms that demonstrate ability to
inhibit its growth. The first aim was to understand the mechanisms by which the
probiont P. inhibens S4Sm protects shrimp from V. parahaemolyticus induced
AHPND, and how the probiont mitigates the pathogenic activity of V.
parahaemolyticus.

The second aim was to isolate and identify a BALO organism, which preys on
V. parahaemolyticus, and to test its safety for use in shrimp aquaculture as a
potential control to prevent the wide-scale growth of V. parahaemolyticus in
aquaculture environments.
14
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Abstract
We have been investigating potential probiotic treatments for Acute
Hepatopancreatic Necrosis Disease (AHPND), affecting farmed shrimp and caused by
the marine pathogen Vibrio parahaemolyticus. In this study we screened over 300
organisms for key probiotic functions, including antibiosis against the pathogen and
biofilm formation. Twelve candidate probionts were screened using Artemia nauplii
and post-larval Litopenaeus vannamei for the in vivo ability to protect against fatal V.
parahaemolyticus infections. We found that Phaeobacter inhibens, which has been
shown to protect oysters and turbot from vibriosis with inhibitory activity against
Vibrio coralliilyticus and Vibrio anguillarum also has potential as a preventative
treatment for AHPND. In infection challenges, pre-treatment with P. inhibens S4Sm
increased the relative survival of L. vannamei post-larvae to 80% as compared to 45%
survival in the infected control. As identified in previous research, the mechanisms of
P. inhibens S4Sm probiotic activity may include its ability to form robust biofilms,
quorum sensing/quorum quenching through N-acyl homoserine lactone (AHL)
signaling, and production of antibiotic tropodithietic acid (TDA). In this study, we find
that V. parahaemolyticus forms biofilms with 3 to 5-fold increased cell density when
co-cultured with P. inhibens S4Sm as compared to a monoculture control.
Additionally, V. parahaemolyticus is not sensitive to TDA at concentrations up to
100 µg/ml. Mutations that disrupt biofilm formation and quorum sensing eliminate
probiotic activity of P. inhibens S4Sm against V. parahaemolyticus.
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Statement of Significance
In this investigation we found that while P. inhibens S4Sm protects Artemia
nauplii and White Leg shrimp (Litopenaeus vannamei) from AHPND. However, it does
not inhibit the growth of the pathogen, suggesting that antibiosis is not a probiotic
mechanism of P. inhibens in preventing AHPND. Rather, probiotic activity is linked to
N-acyl homoserine lactone (AHL) signal production and biofilm formation. The
advantage of a probiotic that does not inhibit the growth of a pathogen is that there
is no selective pressure for the pathogen to develop resistance to the probiont,
making such an organism an attractive option for long-term use in the prevention of
disease. Further, resistance to TDA has not previously been observed outside of the
Roseobacter genus.

Introduction
Shrimp aquaculture is a multi-billion dollar global industry with production
estimated between 2.9-3.5 billion tons in 2017 with 75-80% of production in South
East Asia (1). The United States alone, imported $6.5 billion of shrimp in 2017, an
increase of 14% from the year before (1). AHPND is the major cause of Early
Mortality Syndrome, responsible for significant losses in the shrimp farming industry.
AHPND usually begins within seven to ten days after ponds are stocked with post
larval shrimp and can cause up to 100% mortality within 30 days (2). Effective
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probiotics may offer a disease control strategy to reduce losses in the shrimp farming
industry without the potentially harmful effects of wide-scale antibiotic use (3).
Probiotics are live microorganisms that, when administered in adequate
amounts, confer a health benefit on the host (4). Research indicates that strong
candidate probiotics are able to inhibit the growth of pathogens through the
production of antibiotic compounds , biofilm formation and quorum sensing/quorum
quenching such as through acyl homoserine lactone (AHL) signaling (5–9) to prevent
disease. Candidate probiotics must also be able to tolerate growth conditions
associated with the pathogen, such as the acidity of the digestive tract or, in the case
of shrimp aquaculture, the salinity of the environment. Most importantly, a probiont
must not reduce the overall health of the host organism while present in a
concentration sufficient for preventing disease.
In this study, we screened ten newly isolated bacteria and two oyster
probionts, Phaeobacter inhibens S4Sm and Bacillus pumilus RI06-95, for antibiotic
activity against an AHPND-inducing strain of V. parahaemolyticus, as well as their
ability to protect Artemia nauplii or Litopenaeus vannamei post-larvae (PLs) from
AHPND V. parahaemolyticus. We found that P. inhibens S4Sm was the only candidate
probiont that both significantly increased the survival of and did not harm either
Artemia nauplii and L. vannamei PLs challenged with AHPND V. parahaemolyticus. To
understand the mechanisms by which P. inhibens S4Sm protected L. vannamei PLs
from AHPND, we performed a series of competitive growth assays using mutant
strains that exhibited decreased production of biofilms, no production of the
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ionophore antibiotic tropodithietic acid (TDA), or knockout mutations in the AHL
signaling pathways. We also tested the ability of the mutant strains to protect PLs
challenged with V. parahaemolyticus.

Results
Selection of an AHPND-inducing V. parahaemolyticus strain.
Ten strains of V. parahaemolyticus, isolated from shrimp farms in southern
Thailand during an outbreak of AHPND were screened for the presence of the priA
and pirB genes by duplex PCR. PCR amplification was performed using primers
VpPirA-284F/R and VpPirB-392F/R as described by Han et al. (10). Of these strains,
six were identified to possess both genes (Fig. 1) and were then used to challenge
Artemia nauplii (Fig. 2). Strain PSU5579 exhibited the highest rate of mortality (92%)
in Artemia nauplii and was selected for use in future experiments. All other strains
tested appeared to be avirulent.

Selection of probiotic organisms:
More than 300 bacterial isolates were screened for probiotic activity against
V. parahaemolyticus with a zone of inhibition (ZOI) assay. Ten isolates produced ZOIs
between 0.1mm and 6.4mm. These candidate organisms that produced a zone of
inhibition, along with the two known marine probionts P. inhibens S4Sm and B.
pumilus RI06-95, were then evaluated for biofilm formation via crystal violet staining
(Fig. 3) to select organisms to test in vivo. Eleven of the 12 candidate probiotic
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microbes produced biofilms significantly larger than the pathogen V.
parahaemolyticus PSU5579 with optical densities between 1.3 and 3.7 at 580 nm.
Only isolate HR-1 failed to produce copious biofilm. The oyster probiont, P. inhibens
S4Sm, consistently produced the most abundant biofilm.
In an effort to identify the candidate probionts, genomic DNA was extracted
from the ten isolates for PCR amplification and sequencing of the 16S rRNA gene as
described in the Methods. The organisms were identified (Table 1) by comparing the
resulting 16S rDNA sequences with the NCBI bacterial ribosomal database (11).
Seven of the isolates were found to be members of the genus Pseudoalteromonas,
two were genus Bacillus, and one was Bowmanella.

Artemia nauplii assay
Artemia are frequently used as a model organism to test for biotoxicity in
marine systems (12). In this assay, Artemia were used to screen candidate probionts
identified above for potential harmful effects in Artemia nauplii prior to their use in
trials with L. vannamei PLs. Pseudoalteromonas strains (JL1, JL15, JL29) significantly
decreased survival of Artemia when the Artemia nauplii were treated with
concentrations at 1×105 CFU/ml, while Bowmanella denitrificans (JL63) did not (Fig.
4). Artemia nauplii were then pre-treated with candidate probionts at concentrations
ranging between 1×104 to 1×107 CFU/ml for 24 hours and then challenged with V.
parahaemolyticus PSU5579 at 105 CFU/ml. Potential probiotics were added every 24
hours and survivors were counted 48 hours post challenge. Pre-treatment with
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Pseudoalteromonas species (isolates GR1, GR4, JL1, JL12, JL15, JL18 and JL29) or B.
denitrificans (isolate JL63) followed by challenge with the pathogen PSU5579 resulted
in the complete killing of the Artemia compared to 37% survival of Artemia the
challenged with PSU5579 alone. (Fig. 5). When Artemia were pre-treated with B.
pumilus strains RI06-95, JL70, and HR1 at 104, 105, or 106 CFU/ml for 24 hours and
then challenged with V. parahaemolyticus PSU5579, there was no significant increase
in survival 48 hours following the challenge when compared to the challenged
control (Fig. 6). Artemia nauplii pre-treated for 24 hours with P. inhibens S4Sm and
then challenged V. parahaemolyticus PSU5579 showed a 1.84-fold increase (to 70%)
in their rate of survival 48 hours post challenge when compared with the challenged
control with survival of 38%. Pre-treated and challenged survival was similar to
survival when treated with P. inhibens S4Sm alone. (Fig. 7). This result suggested that
since P. inhibens S4Sm was not harmful to Artemia and was able to reduce AHPND
mortalities in Artemia challenged with V. parahaemolyticus PSU5579, it should be an
excellent candidate probiont for L. vannamei.
Shrimp trials
In initial trials to examine the safety of the candidate probionts, L. vannamei
PLs were treated with candidate probionts at 106 CFU/ml every 24 hours for 72 hours
and survivors were counted. Most strains tested did not significantly decrease
survival of shrimp PLs; however, P. piscicida JL1 significantly decreased survival to
83% compared to 97% survival in the untreated control (Fig. 8). To test the efficacy
of the probiont candidate strains, shrimp pre-treated with the probiotic isolates were
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challenged at 24 hours with V. parahaemolyticus PSU5579 at 106 CFU/ml. They were
followed for 48 hours post-challenge and survivors were counted. Shrimp treated
with either P. inhibens S4Sm or P. piscicida JL1 showed significant protection against
AHPND when compared to the challenged control (Fig. 9); however, since JL1-treated
shrimp exhibited decreased survival even when not challenged with PSU5579, S4Sm
was selected as the best candidate probiont.
A series of experiments were performed to determine which probiotic
characteristics of P. inhibens S4 were critical to protecting L. vannamei from V.
parahaemolyticus PSU5579. These trials were altered from the original experimental
design to prevent the L. vannamei microbiome from confounding experimental
results. In this set of experiments, bottles containing 200 ml 3% artificial sea water
(ASW) plus P. inhibens wild type or mutant strains at a concentration of ~106 CFU/ml
were allowed to incubate for 24 hours at 29oC. Shrimp were added to the bottles
after 24 hours and immediately challenged with V. parahaemolyticus PSU5579 at 106
CFU/ml. P. inhibens treatments were repeated every 24 hours and survivors were
counted 48 hours post-challenge. The relative rates of survival for shrimp treated
with wild type P. inhibens S4SmKm, or the clpX (WZ10) mutant strain (no TDA
production) or the luxO (CS003) mutant (over-produces TDA) were the same (76.5 %
to 80%). In contrast, the relative rates of survival for shrimp treated with the exoP
(WZ20) mutant strain (reduced biofilm formation; 51.5%), or pgaI mutant strain
(lacking biofilm, TDA production and AHL signal production; 59%), or the pgaR
mutant strain (lacking biofilm, TDA production and AHL signal reception; 53%) were
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not significantly different from the 45% survival rate in PSU5579 challenged control
shrimp (Fig. 10). We did not test revertants or complements of these mutant strains;
however, Zhao et al (6) found that complementation of the clpX and exoP genes in
mutant strains restored function to wild type levels. These data strongly suggest that
biofilm formation and quorum signaling are necessary for the probiotic activity of P.
inhibens S4Sm, while TDA production is not necessary.

Competitive biofilm assays
In an effort to understand the competition between pathogen (PSU5579) and
probiont (S4Sm), we used a modification the glass coverslip assay developed by Zhao
et al (6). We found that P. inhibens S4SmKm did not inhibit the biofilm formation of
V. parahaemolyticus PSU5579 when the two organisms were co-cultured (Fig. 11). In
fact, at all times the biofilm cell density of PSU5579 in co-culture with S4SmKm was
increased compared to the PSU5579 monoculture biofilm. The increases in biofilm
were 5.5-fold at 24 h, 3-fold at 48 h, and 3.7-fold at 72 h. The biofilm density of S4Sm
was not affected by co-culture. This contrasts with the probiotic activity of P.
inhibens S4Sm against other Vibrio species, where pathogen biofilm cell density was
decreased when in co-culture (6).
Mutant strains of P. inhibens S4SmKm (clpX, luxO, or pgaI) were tested for
their ability to affect either biofilm formation or planktonic cell density of V.
parahaemolyticus PSU5579. Co-culture of PSU5579 with any of the three mutants
resulted in less robust biofilm formation (Fig. 12a). Planktonic cell concentration of
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V. parahaemolyticus PSU5579 was not reduced when grown in co-culture with any of
the mutant strains compared to co-culture with the wild type of P. inhibens S4SmKm
(Fig. 12b).

TDA Assay
Since the ability of P. inhibens to provide protection against V.
parahaemolyticus PSU5579 was not affected by their ability to produce TDA, we
wanted to determine the minimum inhibitory concentration (MIC) of TDA against V.
parahaemolyticus PSU5579. Briefly, V. parahaemolyticus PSU5579 (initial density 105
CFU/ml) was grown in mLB30 (27°C, 24 h) in the presence of different concentrations
of TDA plus two controls, one containing 1% DMSO, (the solvent in which TDA is
dissolved) and one without additions. Cell density was determined by serial dilution
and spot plating. Vibrio coralliilyticus RE22 and Vibrio anguillarum NB10Sm are
inhibited at 6.25 µg/ml and 1.25 µg/ml, respectively (6). In contrast, V.
parahaemolyticus PSU5579 growth was not inhibited by TDA at concentrations up to
100 μg/ml. These data demonstrate that TDA production does not inhibit V.
parahaemolyticus PSU5579 growth.

Discussion:

In this study we screened more than 300 isolates for probiotic activity. First,
we examined antibiosis using a ZOI assay. Antibiosis is considered one the of the key
and necessary functions of probiotic organisms, enabling them to establish in the
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host environment through competitive advantage and also to fend off potential
pathogens (13). Next we considered biofilm formation. A biofilm is an assemblage of
microbial cells that is associated with a surface and enclosed in a matrix of primarily
polysaccharide material (14). Formation of dense biofilms by probiotics is considered
protective because it allows the probiont to establish long-lasting colonization of the
host and prevent colonization by pathogens (15). In some strains of Lactobacilli, it has
been observed that the exopolysaccharide (EPS), which binds the bacteria to a
surface, can also prevent biofilm formation by pathogens (15). The aquatic
environment allows for the possibility that colonization of the environment may be
an effective alternative to probiotic colonization of the gut (16). Perhaps the most
important feature of a probiotic treatment is that it not cause harm to the host (17).
After completing challenge assays in both Artemia nauplii and shrimp PLs, a single
organism met all these criteria. P. inhibens S4Sm produces the potent antibiotic TDA,
forms the most robust biofilms of the twelve organisms selected for trials, and it did
not cause significant harm for either model organism when used as a
monotreatment. Specifically, P. inhibens S4Sm had no negative effects on L.
vannamei and had the least negative effect (decline of ~15%) on Artemia compared
to all other candidates tested.
In challenge assays, we found that P. inhibens S4Sm protects Artemia nauplii
and L. vannamei from the pathogen V. parahaemolyticus PSU5579. Zhao et al (6, 18)
identified three key characteristics in P. inhibens S4Sm’s ability to protect against V.
coralliilyticus and V. anguillarum (TDA production, biofilm formation and AHL
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signaling); however, these functions are not equally important in all systems. V.
anguillarum is highly sensitive to TDA, at concentrations as low as 1.25 µg/ml (6), but
the disruption of AHL signaling has little impact on the inhibitory activity of
Phaeobacter gallaenciensis against this fish pathogen (19). In contrast, V.
coralliilyticus is less sensitive to TDA at 6.25 µg/ml (6); however, AHL signaling plays a
significant role in the downregulation of virulence factors, and is a component critical
to the protective functions of P. inhibens S4Sm against this oyster pathogen (18).
Upon identifying P. inhibens S4Sm as a candidate probiotic to protect shrimp
from AHPND, we investigated these three probiotic functions to determine which
were critical to protect shrimp against the pathogenic activity of V.
parahaemolyticus. Our data suggest that the reduction of quorum
sensing/quenching signaling through mutation of the AHL synthase (pgaI) or
transcriptional activation/response regulation (pgaR) or reduced AHL concentration
due to decreased biofilm formation (exoP) decreases the probiotic function of P.
inhibens S4Sm. P. inhibens S4Sm mutant strains CS001 (DpgaI) and CS002 (DpgaR)
did not provide significant protection of PLs when compared to the infected control
(Fig. 10). These mutant strains together encode for a luxIR homologous AHL
mediated quorum sensing system. The pgaI gene encodes for the N-3hydroxydecanoylhomoserine lactone (3-OH C(10)-HSL) synthase and, therefore, a
mutation in this gene disrupts AHL production. pgaR encodes for the AHL response
regulator. While this mutant can produce the AHL signal, it does not engage in the
positive feedback loop triggered by the reception of the AHL signal from neighboring
33

cells (20). Cell to cell signaling and biofilm formation are intricately connected (21). In
general, cells in biofilms encounter much higher local cell densities, and therefore
higher concentrations of AHL signals than free-floating planktonic cells (22); as a
result, the disruption of the pgaIR system also reduces biofilm formation. Likewise
the DexoP mutant WZ20, which has 40% or less of the biofilm formation of wild type
cells (6) also has decreased AHL activity due to the reduced localized cell
concentration. WZ20 does not, however, have reduced TDA activity and Zhao et al
(6) found it had delayed inhibitory activity against TDA-sensitive Vibrio species. Given
the common features of these three mutant strains, which are the interconnected
functions of AHL signaling and biofilm formation, and their shared inability to protect
shrimp from AHPND, we conclude that AHL signaling and biofilm formation are
critical to the probiotic activity of P. inhibens S4Sm in protecting shrimp. As Zhao et
al (18) showed that the AHL activity of P. inhibens S4Sm downregulates virulence
factors in V. coralliilyticus RE22, we propose studying the effects of AHL signaling
upon the regulation of AHPND related virulence factors.
Having explored the functions of AHL signaling and biofilm formation, the
remaining known probiotic feature of P. inhibens S4Sm is the production of the
antibiotic ionophore, TDA. In contrast to the effects of P. inhibens on the oyster and
fish pathogens (Alliiroseovarius crassostreae, V. coralliilyticus, and V. anguillarum) (6,
23–25), the growth of V. parahaemolyticus PSU5579 is not inhibited by either P.
inhibens S4Sm or pure TDA. The negative results of both the TDA growth inhibition
assay and the competition assays suggest that V. parahaemolyticus PSU5579 is
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resistant to TDA produced by P. inhibens S4Sm. This observation is notable for two
reasons. First, because P. inhibens S4Sm does not inhibit the growth of PSU5579, it is
potentially an excellent probiotic for long-term use in shrimp aquaculture as there is
no selective pressure for the pathogen to develop resistance to the probiotic
mechanisms of P. inhibens. In fact, competition assay data suggest these two
organisms are mutualistic, growing as well, if not better when co-cultured in biofilms
(Fig. 11). Second, naturally occurring resistance to TDA has not previously been
observed outside the Roseobacter genus (26, 27). This unexpected result suggests
that P. inhibens S4Sm is a particularly strong candidate as a probiotic, because,
without growth inhibition, there is no selective advantage for V. parahaemolyticus
PSU5579 to develop resistance to this probiont.

Materials and Methods:
Bacterial strains and culture conditions
Bacterial species and strains used in this study are listed in Table 1. All
bacteria were grown at 27°C with shaking. P. inhibens S4Sm wild type and mutant
strains were routinely grown to stationary phase in marine yeast peptone 30 (mYP30; 5
g/L peptone, 1 g/L yeast extract, 30 g/L Instant Ocean®, pH7.5) for 48 h. V.
parahaemolyticus PSU5579Sm was grown to stationary phase in LB30 (10 g/L
tryptone, 5 g/L yeast extract, 30 g/L Instant Ocean®, pH7.5) for 24 h.
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Duplex PCR for the detection of pirA- and pirB genes
Ten strains of V. parahaemolyticus isolated from shrimp farms in the Pattani
and Songkla provinces of southern Thailand during an AHPND outbreak were
screened for the presence of the pirA- and pirB genes. The V. parahaemolyticus
strains were gifted by Dr. John Mekalanos (Harvard Medical School). Genomic DNA
was isolated using the Bio Basic EZ-10 Spin Column Bacterial Genomic DNA Miniprep
Kit. Primers VpPirA-284F (5’-TGACTATTCTCACGATTGGACTGR-3’), VpPirA-284R (5’CACGACTAGCGCCATTGTTA-3’), VpPirB-392F (5’-TGATGAAGTGATGGGTGCTC-3’), and
VpPirB-392R (5’-TGTAAGCGCCGTTTAACTCA-3’) were used to amplify the pirA- and
pirB genes (10). 1 µl of extracted gDNA (10-60 ng/µl) was combined with 1 µl of each
primer (10 µmol), 7.5 µl nuclease-free water, and 12.5 µl of QIAGEN Taq PCR master
mix. Reaction conditions were 94 °C for 3 min, followed by 35 cycles of 94 °C for 30 s,
60 °C for 30 s, and 72 °C for 30 s; and a final extension at 72 °C for 7 min. PCR
products were separated on a 2% agarose gel containing ethidium bromide (0.4
µg/ml) and visualized on a UV transilluminator. Presence of pirA is indicated by a
band at 284 bp, while presence of pirB is indicated by a band at 392 bp (28).

16S rRNA gene sequencing
Genomic DNA was isolated using the Bio Basic EZ-10 Spin Column Bacterial
Genomic DNA Miniprep Kit. Primers 27F (5’-AGAGTTTGATCCTGGCTCAG-3’) and
1525R (5’-AAGGAGGTGWTCCARCC-3’) were used to amplify the 16S rRNA gene (11).
Extracted gDNA (1 µl at a concentration of 10-60 ng/µl) was combined with 1 µl of
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each primer (stock solution, 10 µmol), 9.5 µl nuclease-free water, and 12.5 µl of
QIAGEN Taq PCR master mix. Reaction conditions were 95 °C for 2 min, followed by
35 cycles of 94 °C for 15 s, 53 °C for 30 s, and 72 °C for 1.5 min; and a final extension
at 72 °C for 5 min. PCR products were sequenced at the University of Rhode Island
Genomics and Sequencing Center. Sequences were compared to the National Center
for Biotechnology Information (NCBI) database of bacterial genomes using nucleotide
to nucleotide basic local alignment search tool (blastn)

Zone of inhibition assay:
V. parahaemolyticus PSU5579Sm was grown for 24 h in mLB30, diluted 100-fold, and
100 µl of the diluted culture was spread on mYP30 agar (YP30 + 1.6% Bacto
Agar). The inoculated agar plates were allowed to dry for 5-15 min and then
candidate probiotic cultures (grown to stationary phase) were spotted onto the
plates (10 µl/spot). Plates were incubated at 27 °C for 24-48 h. Zones of inhibition,
defined as the distance between the growth of the probiotic organism and the lawn
of V. parahaemolyticus, were measured in mm (28).

Biofilm assay
Biofilm formation was quantified using a modification of the crystal violet
staining method (6). Bacteria were grown for 24 h before being diluted 103-fold into
200 µl of mYP30 in a polystyrene 96-well plate which was then incubated at 27 °C for
24 h under static conditions. Biofilms in the wells were washed with ASW twice,
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stained with 0.2% crystal violet for 20 min, washed twice with ASW, and biofilmbound crystal violet was eluted with 95% ethanol for 30 min before being measured
at OD580. Each candidate probiont was tested in three wells per experiment and each
experiment was repeated twice.

Artemia nauplii challenge
Artemia cysts (0.075 g) were hatched in an inverted 60 ml syringe, covered
with perforated plastic wrap, containing 60 ml HEPPS-buffered (10 mM, pH 8.2)
sterile ASW at 28 °C for 24 h with constant aeration and fluorescent light. To
maintain pH and maximize Artemia hatching rate, an increased buffer capacity is
required to avoid a drop in the pH due to the acid produced by cysts during hatching
(29). Hatched nauplii (2 ml, containing approximately 400 nauplii) were transferred
to 50 ml centrifuge tubes containing 26.3 ml HEPPS-buffered (10 mM, pH 8.2)
ASW. Nauplii were fed autoclaved Escherichia coli K-12 cells at a final concentration
of 107 cells/ml during hatching and every 24 h. Candidate probionts were washed
twice in sterile ASW by centrifugation at 6,000 × g for ten minutes at 4 °C. Nauplii
were treated with candidate probionts after hatching and every 24 h. The centrifuge
tubes were placed in a rotator set to 4 rpm at 30 °C. After incubation for 24 h, 1.6 ml
mYP30 was added to each tube and nauplii were challenged with 1×105 CFU/ml
washed V. parahaemolyticus cells. V. parahaemolyticus cells were washed twice in
sterile ASW by centrifugation at 5,000 × g for five minutes at room temperature. To
count nauplii, the tubes were inverted five times to mix the nauplii suspension, 1 ml
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of the nauplii suspension was transferred into each well of a tri-well petri dish
containing 5 ml of ASW with 0.05% agar (to slow nauplii movement during counting),
and nauplii were viewed under a dissecting microscope. Nauplii were counted at 24
h and 72 h to quantify survival. Nauplii which showed any signs of movement were
counted as alive. Each treatment was tested in three tubes and was repeated twice.
Water in each tube was not changed during the experiment.

White leg shrimp (L. vannamei) post-larvae challenge:
L. vannamei post-larvae (PL) were purchased from Miami-Aquaculture
(Boynton Beach, Florida) and maintained in 3% ASW in a 20L aquarium tank with
filtration and weekly water changes. PLs were fed Hagen® Fluval® Shrimp Granules
daily. PLs were transferred to 250 ml glass bottles with 200 mL 3% ASW and
provided aeration through air stones. PLs were pre-treated with potential probionts
at 106 CFU/ml every 24 hours. After the initial 24 h incubation, PLs were challenged
with V. parahaemolyticus cells at a concentration of 106 CFU/ml, which were grown
for 24 h in mLB30 and harvested by centrifugation (6,000 x g, 5 min, 4C), and washed
twice in ASW. PLs were incubated at 29 °C and survivors were counted at 24, 48 and
72 h time points (28).

Competitive Biofilm assay:
The competitive biofilm assay was carried out using a modification of the
assay developed by Zhao et al (6). Probiotic bacteria were grown for 24 h, added to 5
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mL of mYP30 in tri-well plates containing UV sterilized glass coverslips at a
concentration of 104 CFU/mL, and incubated at 27 °C for 24 h. After 24 h the
coverslips were removed, washed in sterile 3% artificial seawater and placed into
fresh mYP30 in a new tri-well plate. At this time, V. parahaemolyticus PSU5579Sm
was added at a concentration of 105 CFU/ml. A cover slip was removed each
subsequent 24 h period, washed in 3% ASW and vortexed for 2 minutes with sterile
glass beads to remove the biofilm. This mixture was serially diluted and spot plated
(10 μl/spot) on mYP30 agar plates to determine concentration in CFU/cover slip. The
supernatant was sampled at the same time to determine planktonic cell
concentration of both organisms using serial dilution and differential media to plate
and count CFU/ml. Samples were taken for up to 96 hours to track the changes in
planktonic and biofilm cell concentrations (6).

Minimum Inhibitory Concentration Assay:
The minimal inhibitory concentrations (MIC) of TDA against V.
parahaemolyticus was assessed using a broth dilution method in microtiter
plates. Overnight bacterial cultures were diluted to 105 CFU/ml in LB30 and treated
with serial dilutions of pure TDA. After 24 h incubation at 27 °C, growth was assessed
using OD600 and serial dilution with spot plating to determine CFU/ml. Three
independent experiments were done and each independent experiment had two
replicates (6).
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Table 1. Bacterial Strains used
Strain

Origin

Characteristics

Reference

Phaeobacter inhibens S4Sm

Healthy oyster

Spontaneous SmR,

[1]

Harboring pSUP203 Kmr

C.
Schuttert

Phaeobacter inhibens
S4SmKm CS4KN
Phaeobacter inhibens DclpX
WZ10

Insertional
mutagenesis

No TDA production

[1]

Phaeobacter inhibens
DexoP WZ20

Insertional
mutagenesis

Reduced Biofilm formation

[1]

Phaeobacter inhibens DpgaI
CS001

Insertional
mutagenesis

No TDA production, no biofilm
formation, no AHL production

C.
Schuttert

Phaeobacter inhibens
DpgaR CS002

Insertional
mutagenesis

No TDA Production, no biofilm
formation

C.
Schuttert

Phaeobacter inhibens DluxO Insertional
mutagenesis
CS003

Increased TDA production

C.
Schuttert

Vibrio parahaemolyticus
PSU5579Sm

Shrimp farms,
Thailand

Spontaneous SmR

(28)

Bacillus pumilus RI06-95

Marine
Sponge

Pseudoalteromonas
piscicida GR1

Seawater

This study

Pseudoalteromonas
flavipulchra GR4

Seawater

This study

Pseudoalteromnas piscicida
JL1

Seawater

This study

Pseudoalteromonas
piscicida JL12

Seawater

This
Study

Pseudoalteromonas
piscicida JL15

Brine Shrimp

This study

Pseudoalteromonas
flavipulchra JL18

Brine Shrimp

This
Study

Pseudoalteromonas
arabiensis JL29

Brine Shrimp

This
Study
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Bowmanella denitrificans
JL63

Whiteleg
Shrimp

This
Study

Bacillus pumilus JL70

Gulf Shrimp
intestines

This
Study

Bacillus pumilus HR1

Lobster Shell

(28)
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Figures

Figure 1. Detection of pirA- and pirB-like genes found on the pVPA3-1 plasmid.
Imaged on a 2% agarose gel with ethidium bromide (0.4 µg/ml). PCR amplification
was performed using primers VpPirA-284F/R and VpPirB-392F/R as described by Han
et al. (10). A band at 284 bp indicates a pirA, while presence of a pirB amplicon is
indicated by a band at 392 bp (28).
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Figure 2. Survival rates of Artemia nauplii when treated with V. parahaemolyticus at
105 CFU/ml 24 hours after hatching. Strain PUS5579 caused the highest mortality
and was selected for use in further experiments (28).
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Figure 3. Biofilm formation quantified by the crystal violet method. Cultures were
grown in 96-well plates for 24 hours at 27 °C. Biofilms in the wells were washed with
ASW, stained with 0.2% crystal violet, washed again, and biofilm-bound crystal violet
was eluted using 95% ethanol and then optical density at 580 nm was measured.
These data are an average of three biological replicates with three technical
replicates per experiment. Error bars equal one standard deviation. * Indicates
statistically significant difference from V. parahaemolyticus PSU5579 (ANOVA
p<0.05) (28).
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Figure 4. Artemia nauplii survival when treated with Pseudoalteromonas strains
alone at 105 CFU/ml daily for 72 h. These data are an average of three biological
replicates with three technical replicates per experiment. Error bars equal one
standard deviation. * Indicates statistically significant difference from the Control
(ANOVA, p<0.05) (28).
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Figure 5. Pseudoalteromonas and Bowmanella strains decreased Artemia nauplii
survival when pretreated for 24 hours at 104 CFU/ml and then challenged with
PSU5579 at 105 CFU/ml. Error bars equal one standard deviation. These data are an
average of three biological replicates with three technical replicates per experiment.
* Indicates statistically significant difference from the V. parahaemolyticus PSU5579
treatment (ANOVA,p<0.05)(28).
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Figure 6. B. pumilus strains did not improve survival of Artemia nauplii. Artemia were
pre-treated with B. pumilus at concentrations of 104 CFU/ml (1E4), 105 CFU/ml (1E5),
or 106 CFU/ml (1E6) and then challenged with V. parahaemolyticus PSU5579 at 105
CFU/ml. Candidate probionts were added every 24 hours and survivors were counted
at 48 hours. These data are an average of three biological replicates with three
technical replicates per experiment. Error bars equal one standard deviation. (28).
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Figure 7. Pre-treatment of Artemia with P. inhibens S4Sm improves survival.
Artemia were pre-treated with P. inhibens S4Sm at 106 CFU/ml for 24 h improves
survival 48 h after challenge with V. parahaemolyticus PSU5579 at 105 CFU/ml. P.
inhibens S4Sm was added at the start of the experiment and every 24 h. These data
are an average of three biological replicates with three technical replicates per
experiment. Error bars equal one standard deviation. Different letters indicate
statistical significance among groups (ANOVA, p<0.05)(28).
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Figure 8. L. vannamei PL survival when treated with probiotic strains alone at 106
CFU/ml daily for 72 h. These data are an average of three independent experiments
with three technical replicates per experiment. Error bars equal one standard
deviation. * Indicates statistically significant difference from the control ANOVA,
p<0.05) (28).
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Figure 9. P. inhibens S4Sm and P. piscicida JL1Sm provide significant protection to L.
vannamei PLs. When L. vannamei PLs were pre-treated with P. inhibens S4Sm and P.
piscicida JL1Sm at 106 CFU/ml and challenged with V. parahaemolyticus PSU5579 at
106 CFU/ml after 24 hours. These data are an average of three biological replicates
with three technical replicates per experiment. Error bars equal one standard
deviation. * Indicates statistically significant difference from the challenged control
(ANOVA, p<0.05) (28).
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Figure 10: Relative shrimp survival when environment was pre-treated with P.
inhibens S4smkm and mutant strains of P. inhibens S4. Shrimp were added at 24
hours and challenged with V. parahaemolyticus PSU5579. These data are an average
of three biological replicates with three technical replicates per experiment. Error
bars equal one standard deviation. * Indicates statistically significant difference from
the uninoculated control shrimp (ANOVA, p<0.05).
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Figure 11. Biofilm formation by V. parahaemolyticus PSU5579 and P. inhibens
S4SmKm is not inhibited during co-culture. These data are a log-transformed average
of at least four biological replicates with three technical replicates per experiment.
Error bars equal one standard deviation.
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Figure 12. The effects of co-culture of V. parahaemolyticus PSU5579 with P. inhibens
S4SmKm wild type (grey) or mutants (luxO (light blue), clpX (green), or pgaR (dark
blue)) on PSU5579 biofilm (panel a) or planktonic (panel b) cell densities. Biofilm or
planktonic cell density for the V. parahaemolyticus PSU5579 only control is shown in
yellow. Time points represent the time after the start of the experiment (addition of
P. inhibens cells, 104 CFU/ml)). V. parahaemolyticus cells were added (105 CFU/ml) at
24 h. These data are log-transformed averages, Error bars represent one standard
deviation.
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Figure 13. Growth of V. parahaemolyticus PSU5579 in LB30 containing various
concentrations of TDA. Cells were inoculated at an initial concentration of 1×105
CFU/ml and incubated at 27°C for 24 h. Final cell densities were determined by
serial dilution and plating. Data are a log-transformed average of two biological
replicates with at least four technical replicates each. Error bars equal one standard
deviation. (28).
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Abstract
The daft genome of Halobacteriovorax sp. GB3, isolated after enrichment on
the Acute Hepatopancreatic Necrosis Disease (AHPND)-inducing Vibrio
parahaemolyticus PSU5579, is presented. The 3.62-Mbp genome of this predatory
bacterium contains 3493 coding sequences. Sequence comparisons between 15
different proteins suggest that this represents a new species of Halobacteriovorax.

Body
Halobacteriovorax, a genus of marine Bdellovibrio and like organisms (BALOs)
within the Deltaproteobacteria, was first differentiated from freshwater
Bacteriovorax in 2015 (1). Currently, two named species belong to this genus:
Halobacteriovorax litoralis and Halobacteriovorax marinus (1, 2). It has been
proposed that BALOs could help prevent AHPND in shrimp aquaculture (3).
Halobacteriovorax sp. GB3 was isolated from Narragansett Bay after enrichment on a
strain of AHPND-inducing Vibrio parahaemolyticus. Sea water was filtered through a
0.45 μm filter to remove sediments and larger organisms. The filtrate was added to
nutrient-free soft agar containing 106 CFU/ml V. parahaemolyticus PSU5579 and
poured onto mYP30 (5 g/L peptone, 1 g/L yeast extract, 30 g/L Instant Ocean®, pH7.5)
+ 1.5% agar plates. Plates were observed for plaque formation after 5 days
incubation at 27oC. Picked plaques were added to stationary phase cultures of V.
parahaemolyticus PSU5579 growing in mLB30 (10 g/L tryptone, 5 g/L yeast extract,
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30 g/L Instant Ocean®, pH7). This process was repeated; co-cultures were visualized
by microscopy to determine if contamination was present. After 7 passes through
the plaque process, the co-cultures were centrifuged at 6,000 ´ g for 5 minutes at
4°C and the supernatant filtered through a 0.22 μm filter. Filtrate was added to a
stationary phase culture of V. parahaemolyticus PSU5579 and grown shaking at 27°C.
After 24 hours the co-culture was observed to be contaminant-free via microscopy.

Genomic DNA was isolated using Promega’s Wizard genomic DNA purification
kit. Halobacteriovorax sp. GB3 was grown shaking overnight at 27°C in a stationary
phase culture of V. parahaemolyticus in mLB30 broth. Cultures were centrifuged for
5 minutes at 6,000 ´ g; supernatant was filtered through a 0.22 μm filter to remove
prey cells. Isolated DNA was resuspended in 2 mM Tris-HCl buffer (Bio Basic).
Sequencing was performed at the Rhode Island Genomics and Sequencing Center
using an Illumina MiSeq Sequencer. Sequence trimming and de novo assembly was
performed using CLC Genomics Workbench (version 12). The resulting contigs were
processed using CLC Microbial Genome Finishing module. The draft genome contains
9 contigs, with a total sequence length of 3,622,901 bp and 36.9% GC content. Gene
annotation was performed using Rapid Annotations using Subsystems Technology
(RAST) resulting in 3493 coding sequences and 39 RNAs (4). 227 SEED subsystems
were identified containing 19% of the coding sequences (5).
The 16S rRNA gene was PCR-amplified from genomic DNA using16S primers
27F (5’-AGAGTTTGATCCTGGCTCAG-3’) and 1525R (5’-AAGGAGGTGWTCCARCC-3’) (6).
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Comparison using the National Center of Biotechnology Information (NCBI) Basic
Local Alignment Search Tool (BLAST), determined the 16S rRNA gene of
Halobacteriovorax sp. GB3 shares 93.47% nucleotide identity with H. litoralis JS5, and
92.87% identity with H. marinus BE01and H. marinus SJ respectively. A RAST
comparison of 15 conserved genes revealed Halobacteriovorax sp. GB3 shares an
average of 80.6% amino acid identity with H. marinus BE01 and H. marinus SJ,
whereas the two H. marinus species are 100% identical across these genes (Table 2).
For these reasons, we propose that Halobacteriovorax sp. GB3 is a novel species.

Accession number(s). The draft genome of Halobacteriovorax sp. GB3 has been
deposited in NCBI Sequence Read Archive (SRA) under BioProject accession number
PRJNA613698
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Table 1. Bacterial strains compared using BLAST analysis
STRAIN NAME

REFERNENCE

HALOBACTERIOVORAX MARINUS BE01

(7)

HALOBACTERIOVORAX MARINUS SJ

(8)

HALOBACTERIOVORAX SP. BALO_7

(9)

HALOBACTERIOVORAX SP. GB3

This Study

Table 2. Comparison of conserved genes
Percent amino acid identity
GB3 Vs
BE01
91.13

GB3 vs
SJ
91.13

GB3 vs
BALO_7
90.15

BE01
vs SJ
100

BE01 vs
BALO_7
88.67

NADH-ubiquinone
oxidoreductase chain B

95.62

95.62

95

100

32.12

Rod shape-determining
protein MreB

93.04

93.04

91.04

100

91.62

LSU ribosomal protein
L14p

92.62

92.62

92.62

100

88.52

LSU ribosomal protein
L16p

91.11

91.11

95.62

100

88.97

SSU ribosomal protein
S10p

93.14

93.14

92.16

100

90.2

Gene name
Na(+)-translocating
NADH-quinone reductase
subunit E
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GB3 Vs
BE01

GB3 vs
SJ

GB3 vs
BALO7

BE01
vs SJ

BE01 vs
BALO7

Cytochrome b/b6,
N-terminal

95.77

95.77

95

100

94.23

DNA-directed RNA
polymerase omega
subunit
SSU ribosomal protein
S12p

91.43

91.43

90

100

88.57

94.35

94.35

91.94

100

92.74

RNA polymerase sigma
factor RpoD

86.11

86.11

81.03

100

79.69

DNA polymerase III beta
subunit

67.92

67.92

61.99

100

60.38

RecA protein

81.77

81.77

84.12

100

82.02

Chaperone protein DnaK

33.21

33.21

33.21

100

86.53

Heat shock protein GroEL

88.83

88.83

86.36

100

83.52

DNA gyrase subunit A

82.68

82.68

79.29

100

78.64

Gene name
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